Current Vascular Pharmacology
Title: Editorial [PCI and Stable Coronary Heart Disease - COURAGE to Change Our Minds?]
Volume: 5 Issue: 3
Author(s): Anna I. Kakafika, Dimitri P. Mikhailidis, Anthony S. Wierzbicki, Asterios Karagiannis and Vasilios G. Athyros
Affiliation:
Keywords: Percutaneous coronary intervention, stents, medical treatment, treatment cost
Export Options
About this article
Cite this article as:
Anna I. Kakafika , Dimitri P. Mikhailidis , Anthony S. Wierzbicki , Asterios Karagiannis and Vasilios G. Athyros , Editorial [PCI and Stable Coronary Heart Disease - COURAGE to Change Our Minds?], Current Vascular Pharmacology 2007; 5 (3) . https://dx.doi.org/10.2174/157016107781024145
DOI https://dx.doi.org/10.2174/157016107781024145 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Puerarin: A Review on the Pharmacological Activity, Chemical Properties
and Pharmacokinetics of Main Isoflavonoid
The Natural Products Journal Plasminogen Activator System and Vascular Disease
Current Vascular Pharmacology Effects of Dietary Polyunsaturated Fatty Acids on Mitochondria
Current Pharmaceutical Design Racial Differences in Gray Matter Integrity by Diffusion Tensor in Black and White Octogenarians
Current Alzheimer Research Vitamin D and Cardiovascular Disease
Current Vascular Pharmacology Phytosterols in Physiological Concentrations Target Multidrug Resistant Cancer Cells
Medicinal Chemistry Pleiotropic Beneficial Effects of Epigallocatechin Gallate, Quercetin and Delphinidin on Cardiovascular Diseases Associated with Endothelial Dysfunction
Cardiovascular & Hematological Agents in Medicinal Chemistry Kinetic Measurement Techniques in the Evaluation of Lipid Metabolism
Current Drug Discovery Technologies May Oxygen-Ozone Therapy Improves Cardiovascular Disorders?
Cardiovascular & Hematological Disorders-Drug Targets Cancer Nanotechnology: Emerging Role of Gold Nanoconjugates
Anti-Cancer Agents in Medicinal Chemistry Herb-Drug Interactions and Mechanistic and Clinical Considerations
Current Drug Metabolism Opportunities for Nano-Formulations in Type 2 Diabetes Mellitus Treatments
Current Pharmaceutical Biotechnology Transdermal Delivery of Captopril and Metoprolol Tartrate with Microneedles
Drug Delivery Letters Pharmacogenomics: A Tool to Prevent and Cure Coronary Heart Disease
Current Pharmaceutical Design The Role of Infection in Carotid Plaque Pathogenesis and Stability: The Clinical Evidence
Current Vascular Pharmacology The Start of a New Era for Stroke Treatment: Mechanical Thrombectomy Devices
Current Neurovascular Research HIV Infection and Myocardial Infarction
Current HIV Research Bioinformatics Analysis of Functional Protein Sequences Reveals a Role for Tumor Necrosis Factor-α and Nitric Oxide in Insulin Resistance Syndrome
Current Nutrition & Food Science Atrial Fibrillation – New Frontiers in Anticoagulation
Cardiovascular & Hematological Disorders-Drug Targets Tetramethylpyrazine Facilitates Functional Recovery after Spinal Cord Injury by Inhibiting MMP2, MMP9, and Vascular Endothelial Cell Apoptosis
Current Neurovascular Research